Mizushina Yoshiyuki, Ishidoh Tomomi, Takeuchi Toshifumi, Shimazaki Noriko, Koiwai Osamu, Kuramochi Kouji, Kobayashi Susumu, Sugawara Fumio, Sakaguchi Kengo, Yoshida Hiromi
Laboratory of Food and Nutritional Sciences, Department of Nutritional Science, Kobe-Gakuin University, Nishi-ku, Kobe, Hyogo 651-2180, Japan.
Biochem Biophys Res Commun. 2005 Dec 2;337(4):1288-95. doi: 10.1016/j.bbrc.2005.10.005. Epub 2005 Oct 10.
We previously reported that a phenolic compound, curcumin (diferuloylmethane), was a selective inhibitor of DNA polymerase lambda (pol lambda) in vitro [Y. Mizushina, M. Hirota, C. Murakami, T. Ishidoh, S. Kamisuki, N. Shimazaki, M. Takemura, M. Perpelescu, M. Suzuki, H. Yoshida, F. Sugawara, O. Koiwai, K. Sakaguchi, Some anti-chronic inflammatory compounds are DNA polymerase lambda-specific inhibitors, Biochem. Pharmacol. 66 (2003) 1935-1944.]. We also found that monoacetylcurcumin ([1E,4Z,6E]-7-(4''-acetoxy-3''-methoxyphenyl)-5-hydroxy-1-(4'-hydroxy-3'-methoxyphenyl)hepta-1,4,6-trien-3-on), a chemically synthesized derivative of curcumin, was a stronger pol lambda inhibitor than curcumin, achieving 50% inhibition at a concentration of 3.9microM. Monoacetylcurcumin did not influence the activities of replicative pols such as alpha, delta, and epsilon, and showed no effect even on the activity of pol beta, the three-dimensional structure of which is thought to be highly similar to that of pol lambda. The compound-induced inhibition of pol lambda activity was non-competitive with respect to both the DNA template-primer and the dNTP substrate. Monoacetylcurcumin did not inhibit the activity of the C-terminal catalytic domain of pol lambda including the pol beta-like core, in which the BRCT motif was deleted. The compound did not influence the activities of prokaryotic pols or other mammalian DNA metabolizing enzymes such as calf primase of pol alpha, calf terminal deoxynucleotidyl transferase, human telomerase, human immunodeficiency virus type-1 reverse transcriptase, T7 RNA polymerase, T4 polynucleotide kinase, and bovine deoxyribonuclease I. Therefore, we concluded that monoacetylcurcumin is a selective inhibitor of pol lambda and could be used as a chromatographic ligand to purify pol lambda. We then made a monoacetylcurcumin-conjugated column with epoxy-activated Sepharose 6B. In the column, pol lambda of full length was selectively adsorbed and eluted.
我们先前报道,一种酚类化合物姜黄素(二阿魏酰甲烷)在体外是DNA聚合酶λ(pol λ)的选择性抑制剂[Y. Mizushina, M. Hirota, C. Murakami, T. Ishidoh, S. Kamisuki, N. Shimazaki, M. Takemura, M. Perpelescu, M. Suzuki, H. Yoshida, F. Sugawara, O. Koiwai, K. Sakaguchi, 一些抗慢性炎症化合物是DNA聚合酶λ特异性抑制剂,生物化学与药物学66 (2003) 1935 - 1944]。我们还发现,单乙酰姜黄素([1E,4Z,6E]-7-(4''-乙酰氧基-3''-甲氧基苯基)-5-羟基-1-(4'-羟基-3'-甲氧基苯基)庚-1,4,6-三烯-3-酮),一种姜黄素的化学合成衍生物,是比姜黄素更强的pol λ抑制剂,在浓度为3.9微摩尔时达到50%抑制率。单乙酰姜黄素不影响诸如α、δ和ε等复制性聚合酶的活性,甚至对pol β的活性也无影响,pol β的三维结构被认为与pol λ高度相似。该化合物对pol λ活性的诱导抑制对于DNA模板引物和dNTP底物均为非竞争性。单乙酰姜黄素不抑制包括pol β样核心(其中BRCT基序被删除)的pol λ的C末端催化结构域的活性。该化合物不影响原核聚合酶或其他哺乳动物DNA代谢酶的活性,如pol α的小牛引发酶、小牛末端脱氧核苷酸转移酶、人端粒酶、人免疫缺陷病毒1型逆转录酶、T7 RNA聚合酶、T4多核苷酸激酶和牛脱氧核糖核酸酶I。因此,我们得出结论,单乙酰姜黄素是pol λ的选择性抑制剂,可作为色谱配体用于纯化pol λ。然后我们用环氧活化的琼脂糖6B制备了单乙酰姜黄素偶联柱。在该柱中,全长的pol λ被选择性吸附并洗脱。